Transaction Overview - The company, COFCO Biotech Co., Ltd., is selling its entire stake in Huishang Bank Co., Ltd. through a public listing on the Shanghai United Assets and Equity Exchange, with the transaction price set at 102.85034694 million yuan [1] - The company holds 40.3095 million shares of Huishang Bank, representing 0.2902% of its total share capital [1] - The initial listing price is based on the net asset valuation of Huishang Bank as of December 31, 2023 [2] Transaction Progress - The public listing price for the shares is set at 156.2796 million yuan, with the first round of bidding scheduled from December 27, 2024, to January 24, 2025 [2] - If no interested buyers are found during the initial listing period, the price will be adjusted downward by no more than 10% of the initial listing price in subsequent rounds [3] Buyer Information - The buyer is Anhui Investment Group Holding Co., Ltd., a state-owned enterprise with a registered capital of 6 billion yuan [3] - The transaction was completed on March 31, 2025, with the buyer's legal representative being He Changshun [3] Financial Indicators of the Buyer - Total assets: 368.56 billion yuan (previous year: 398.22 billion yuan) [5] - Total equity: 182.08 billion yuan (previous year: 195.34 billion yuan) [5] - Operating income: 33.99 billion yuan (previous year: 35.64 billion yuan) [5] - Net profit: 5.26 billion yuan (previous year: 4.99 billion yuan) [5] Purpose and Impact of the Transaction - The sale aligns with the company's strategic development needs by divesting from financial institutions that do not strongly correlate with its core business, thereby mitigating financial risks [6] - The transaction is not expected to adversely affect the company's normal operations or harm the interests of its shareholders [6]